Analyst Consensus ?
ConsensusBuy27 ratings
Bullish2074.1%
Neutral622.2%
Bearish13.7%
MSCI Inc. · MSCI · FY2025 Q4 · Calendar Q1 2026
MSCI reports strong Q4 growth as AI investment expands
The supplied analysis supports a constructive operating picture: strong organic growth, ETF-linked demand, AI-enabled product development and private-market expansion provide growth support. The key tests are whether AI produces measurable efficiency gains, retention remains stable and investment spending converts into durable cash flow.
Reported Before market openNYSEFinancial Services
$39.46B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$4.66
Consensus $4.60
EPS surprise
+1.3%
Reported versus consensus
Reported revenue
$822.5M
Consensus $822.4M
Revenue surprise
+0.0%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+5.7%
Event window
SPY move
-0.0%
Same window
Abnormal move
+5.7%
Stock minus SPY
Volume
2.5×
Versus trailing sessions
Subsequent drift
-6.8%
Up to 20 sessions
MSCISPY benchmark
Ask FN2 about MSCI FY2025 Q4
Transcript, numbers and history already loaded
Why did MSCI rise 5.7% after beating EPS estimates in FY2025 Q4?What changed in MSCI's guidance and outlook in FY2025 Q4?Give me the bull and bear case for MSCI after FY2025 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior analysis, MSCI’s current quarter adds evidence of broad AI deployment, an extended BlackRock ETF licensing agreement through 2035, and continued expansion of private-market and custom-index products. Guidance sentiment moved from raised in the prior analysis to maintained in the current analysis, while capex is described as increasing.
Guidance delta
Management maintained its guidance stance; the supplied analysis does not provide a revised numerical range.
Key takeaways
- Organic revenue grew by more than 10% year over year, while adjusted EBITDA rose 13% and EPS increased 12% in Q4.
- The run-rate exceeded $3.3 billion, with asset-based fees up 26% and subscription revenue up 13%.
- Management is embedding AI across products while continuing investment in private-market tools and share repurchases.
Management priorities
- Embed AI in analytics and custom-index products.
- Expand private-capital pricing, tokenization-related products and integrated risk tools.
- Build the new London office and continue product development across index, analytics and sustainability offerings.
Follow MSCI with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$536.36Current
$543Low
$646.29Average
$760High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 10, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 8, 2026 |
| UBS | Buy | Buy | Maintain | Apr 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 22, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Dec 18, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 12, 2024 |
| Redburn Atlantic | Buy | Neutral | Upgrade | Oct 9, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 26, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Apr 24, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 9, 2024 |
| Redburn Partners | Neutral | Buy | Downgrade | Sep 14, 2023 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Jul 17, 2023 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 8, 2020 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Feb 12, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 11, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Oct 11, 2019 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 3, 2017 |
| Macquarie | Neutral | Neutral | Maintain | Feb 5, 2016 |
| Cantor Fitzgerald | Buy | Buy | Maintain | Nov 10, 2015 |
| Keefe, Bruyette & Woods | Market Perform | Underperform | Upgrade | Nov 2, 2015 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Nov 2, 2015 |
| Janney Capital | Buy | Buy | Maintain | Dec 12, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $536.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $722 | $569.86 | +34.6% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $690 | $561.74 | +28.6% | Jul 22, 2026 |
| UBS | Analyst unavailable | $615 | $561.74 | +14.7% | Jul 22, 2026 |
| Morgan Stanley | Toni Kaplan | $700 | $561.74 | +30.5% | Jul 21, 2026 |
| Barclays | Manav Patnaik | $735 | $603.35 | +37.0% | Jul 10, 2026 |
| Raymond James | Patrick O'Shaughnessy | $760 | $597.24 | +41.7% | Jul 8, 2026 |
| Redburn Partners | Analyst unavailable | $690 | $596.89 | +28.6% | Jun 18, 2026 |
| Wells Fargo | Jason Hass | $700 | $588.52 | +30.5% | May 27, 2026 |
| Raymond James | Patrick O'Shaughnessy | $730 | $589.17 | +36.1% | Apr 21, 2026 |
| Deutsche Bank | Analyst unavailable | $715 | $605.47 | +33.3% | Jan 29, 2026 |
| Evercore ISI | David Motemaden | $690 | $607.3 | +28.6% | Jan 29, 2026 |
| RBC Capital | Ashish Sabadra | $655 | $604.54 | +22.1% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $618 | $614.87 | +15.2% | Jan 29, 2026 |
| UBS | Analyst unavailable | $638 | $614.87 | +18.9% | Jan 28, 2026 |
| Raymond James | Patrick O'Shaughnessy | $690 | $586.47 | +28.6% | Jan 12, 2026 |
| UBS | Analyst unavailable | $710 | $593.76 | +32.4% | Oct 29, 2025 |
| UBS | Analyst unavailable | $601 | $593.76 | +12.1% | Oct 29, 2025 |
| Barclays | Manav Patnaik | $660 | $593.76 | +23.1% | Oct 29, 2025 |
| Seaport Global | Analyst unavailable | $650 | $567.41 | +21.2% | Oct 1, 2025 |
| Goldman Sachs | George Tong | $723 | $597.9 | +34.8% | Dec 18, 2024 |
| Goldman Sachs | George Tong | $617 | $578.93 | +15.0% | Oct 30, 2024 |
| Morgan Stanley | Toni Kaplan | $662 | $578.93 | +23.4% | Oct 29, 2024 |
| Barclays | Manav Patnaik | $700 | $559.75 | +30.5% | Sep 13, 2024 |
| Wells Fargo | Jason Haas | $570 | $532.41 | +6.3% | Aug 12, 2024 |
| Argus Research | John Eade | $600 | $544.6 | +11.9% | Jul 26, 2024 |
| UBS | Alex Kramm | $585 | $493 | +9.1% | Jul 9, 2024 |
| RBC Capital | Ashish Sabadra | $638 | $498.31 | +18.9% | Jun 6, 2024 |
| Goldman Sachs | George Tong | $526 | $503.83 | -1.9% | May 23, 2024 |
| Deutsche Bank | Faiza Alwy | $569 | $468.5 | +6.1% | Apr 24, 2024 |
| J.P. Morgan | Analyst unavailable | $585 | $561.94 | +9.1% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $543 | $538.02 | +1.2% | Feb 1, 2023 |
| RBC Capital | Analyst unavailable | $600 | $537.72 | +11.9% | Feb 1, 2023 |
| Oppenheimer | Analyst unavailable | $575 | $532.18 | +7.2% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $549 | $531.56 | +2.4% | Feb 1, 2023 |
| Raymond James | Patrick O'Shaughnessy | $539 | $505.24 | +0.5% | Jan 15, 2023 |
| Morgan Stanley | Analyst unavailable | $518 | $473.58 | -3.4% | Jan 4, 2023 |
| J.P. Morgan | Analyst unavailable | $580 | $522.87 | +8.1% | Dec 13, 2022 |
| Barclays | Analyst unavailable | $600 | $521.39 | +11.9% | Dec 2, 2022 |
| RBC Capital | Ashish Sabadra | $520 | $429.78 | -3.1% | Jun 28, 2022 |
| Barclays | Manav Patnaik | $470 | $416.71 | -12.4% | Jun 24, 2022 |
| Deutsche Bank | Analyst unavailable | $477 | $420.22 | -11.1% | Apr 27, 2022 |
| Barclays | Analyst unavailable | $570 | $422.42 | +6.3% | Apr 27, 2022 |
| Morgan Stanley | Analyst unavailable | $540 | $424.62 | +0.7% | Apr 27, 2022 |
Track every rating change on MSCI the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMSCI Inc., alongside its subsidiaries, offers sophisticated tools and services to support global investment decision-making and process management for its clients. The company is structured into four key segments: Index, Analytics, ESG and Climate, and Private Assets. The Index division furnishes benchmarks employed across diverse investment applications, including the creation of indexed financial products such as ETFs, mutual funds, and various derivatives; performance evaluation; portfolio building and adjustment; and strategic asset allocation. This segment also oversees the licensing of GICS and GICS Direct. Its Analytics segment provides comprehensive solutions for risk management, performance attribution, and portfolio oversight, encompassing content, applications, and services. These offerings deliver an integrated perspective on risk and return, alongside detailed analysis of market, credit, liquidity, and counterparty risks across all asset classes.…
Historical context
All MSCI earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
Get the MSCI recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-29T16:56:11.442633+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T16:56:11.439816+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.